ASH Scotland welcomes the tightening of regulations on advertising and promoting e-cigarette products as a step towards protecting the health of Scottish children, young people, and non-smoking adults.
Earlier this year, the Scottish government conducted a consultation seeking views on proposed regulations aimed at balancing the protection of non-smokers and providing information to smokers.
Sheila Duffy, the CEO of ASH Scotland, expressed her welcome for the release of the report, stating a hope for action to be taken towards implementing the advertising and promotional restrictions that were passed by the Scottish Parliament and became law in 2016. Reports of significantly increased usage of disposable e-cigarettes among children and young people make these measures urgently needed.
Promoting new products is a clear way for the tobacco industry to reach potential consumers for future generations. Seeking opinions on measures to curb advertising and promotion of recreational novels is crucial in protecting young people from being tempted to experiment.
Young people who try electronic cigarettes are at a much higher risk of developing nicotine addiction and later transitioning to tobacco use. We all hope to spare our children this prospect, as smoking is a direct cause of 16% of all deaths in Scotland.
Duffy added, "The World Health Organization expressed concern that children who use these products may be three times more likely to use tobacco products in the future. This concern was also supported by a global systematic evidence review published by Australians earlier this year.
The long-term health risks of e-cigarettes are largely unknown. However, it is known that most e-cigarettes contain nicotine, which is highly addictive, and that the e-liquid may also contain other toxic elements. Lesser harm does not mean harmless.
Most adults have heard of electronic cigarette products, which can be purchased and used if one wishes, but they are not approved smoking cessation products. Rather, they are primarily marketed as commercial entertainment products, with features such as color, flavor, and price intended to attract children and adolescents. The NHS does not offer electronic cigarettes as part of its prescription service. Rather, we encourage anyone looking to quit smoking to seek out local pharmacies or smoking cessation services, which offer person-centered approaches to quitting.
Statement:
The content of this article is compiled from third-party information and is only intended for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The translation of this article is intended for industry communication and research purposes only.
Due to limitations in translation ability, the translated article may not express the original text exactly. Please refer to the original for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related expressions and stances.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
